Purpose The role of inflammation and fibrinolysis for the development of back pain and sciatica has been discussed. The aim of this study was to assess the relationship between markers of inflammation and fibrinolysis, to predict the outcome after surgery for lumbar disc herniation. Methods 177 patients were recruited. High sensitive C-reactive protein (hsCRP), plasminogen activator inhibitor 1 (PAI-1), fibrinogen, and D-dimer were analyzed preoperatively. Visual analogue scale (VAS) for back and leg pain, Oswestry Disability Index (ODI), and EuroQol 5 Dimensions (EQ-5D) were assessed preoperatively and at 6 weeks, 6-, 12-, and 24-months postoperatively. Dichotomization was made at the median for the laboratory analyses, and between the worst quartile and the other three quartiles for the outcome variables. Logistic regression was used to determine the odds ratios (OR) and 95 % confidence intervals (CI). Results The associations between PAI-1 and outcome seemed to be most prominent at the 6 and 12-month follow-up. When being in the upper half of PAI-1, the OR for being in the worst quartile of VAS back pain 12 months postoperatively was 3.33 (1.56-7.10). The corresponding OR for VAS leg pain was 2.46 (1.18-5.10), for ODI 2.83 (1.35-5.94) and for EQ-5D 2.73 (1.30-5.75). The OR for hsCRP was 2.10 (1.03-4.29) for being in the worst quartile of VAS back pain. Fibrinogen or D-dimer was not associated with any outcome variable. Conclusions High PAI-1, a marker of fibrinolysis, was fairly consistently associated with poor outcome, while hsCRP, fibrinogen, and D-dimer were not.
Introduction
Outcome after surgery for lumbar disc herniation is considered poor in about 25 % of patients [1, 2] . If patients at risk for a poor outcome could be identified, surgery may be avoided and other treatments offered.
Local inflammation is part of the etiology of pain in lumbar disc herniation [3] . Inflammatory factors have been detected in the epidural space in patients with degenerative lumbar disorders and pain [4] . The high sensitivity C-reactive protein test (hsCRP) is one of the most sensitive indicators of inflammation in peripheral blood. Sugimori et al. [5] found higher hsCRP in patients with lumbar disc herniation than in healthy controls. In a surgically treated subsample of their study (n = 17), there was a positive correlation between the preoperative hsCRP and a poorer recovery at follow-up ranging from 6 to 12 months. Another study reported that the severity of acute sciatic-, but not chronic low back pain, was associated with high hsCRP [6] . In a large population-based cross-sectional study (n = 15,322), Briggs et al. [7] reported that high CRP was associated with an increased odds ratio of low back pain during the last 3 months.
Impaired fibrinolytic activity has been reported in patients with chronic back pain compared to healthy controls and it has been speculated that this may be associated to inflammation and scarring as a source of pain [8, 9] . The major regulator of the fibrinolytic system is plasminogen inhibitor 1 (PAI-1) and elevations of PAI-1 are associated with impaired fibrinolytic activity. PAI-1 and other components of the fibrinolytic system are also involved in inflammation, arteriosclerosis, cancer, and the development of fibrosis [10] [11] [12] . Impaired fibrinolytic activity, as measured with PAI-1, has been associated with inferior outcome in patients operated for lumbar disc herniation (n = 122) [13] . Higher fibrinogen levels have been reported in individuals with pain in the shoulder, neck, upper or lower back compared to individuals without pain [14] . However, contradictory results exist [7, 15] .
Thus, we hypothesized that markers of inflammation and fibrinolysis could be associated with pain, disability, and quality of life in patients with lumbar disc herniation and predict the outcome after surgery.
Patients and methods

Patients
Patients admitted for lumbar disc herniation surgery at Södersjukhuset, Stockholm, Sweden, were invited to participate in this prospective observational study. Inclusion criteria were one-level lumbar disc herniation, radiculopathy with corresponding MRI finding, and a duration of more than 2 months, or earlier if requiring hospitalization, a need of 25 % or more of sick leave or similar disability, and an age of 18 years or older. Exclusion criteria were cauda equina impaction requiring urgent surgery, previous lumbar spine surgery, and conditions that could affect follow-up or outcome interpretation, such as psychiatric illness, drug abuse, or severe co-morbidity.
During the period Nov. 2004 through Nov. 2010, a total of 239 patients fulfilled the inclusion criteria. Of these, 185 were informed about the study, and 180 accepted participation, while 5 declined. Shortly after surgery, 3 patients were found to have been included incorrectly, and therefore, 177 remained as study population. All surgeries were performed by one of the 4 senior consultants, using standard technique, with or without microscope. Postoperative treatment was uniform and included early mobilization. Non-steroidal anti-inflammatory drugs were prescribed to all who tolerated it (n = 130). Low molecular heparin was not used as a routine, but usually prescribed for non-elective patients (n = 43).
Outcome assessment
A self-assessment questionnaire was administered preoperatively, at 6 weeks, 6, 12, and 24 months postoperatively. 177, 174, 172, 173, and 175 patients responded to the questionnaire at the different time points, respectively. To measure back-and leg pain, we used the 100-mm visual analogue scale (VAS) and the patients were asked to estimate their average pain the preceding week [16] . The Oswestry Disability Index (ODI) was used to measure back function, which gives a score from 1 (best) to 100 (worst) [17, 18] . The EuroQol-5 Dimensions-3 Levels (EQ-5D) was used to measure general quality of life, which gives an index between -0.59 (worst) and 1 (best) [19] . The preoperative questionnaire also included questions on anthropometry and smoking habits.
Laboratory analyses
Preoperatively, morning fasting blood samples were drawn. After centrifugation, aliquots with platelet-poor plasma were frozen and stored at -70°C before the analyses of hsCRP, PAI-1, fibrinogen, and D-dimer at the Department of Clinical Chemistry, Karolinska University Hospital. These analyses were performed at two different times with 60 samples analyzed first, and 117 later. HsCRP was analyzed on frozen serum samples by nephelometry on BN ProSpec (Siemens Healthcare AG, Erlangen, Germany). The plasma activity of PAI-1 was determined by a functional enzymatic ELISA assay, Biopool Chromolyze/TriniLIZE PAI-1 Activity (Trinity Biotech, Wicklow, Ireland). Fibrinogen was analyzed with Dade Thrombin reagent (Siemens Healthcare AG, Erlangen, Germany) and D-dimer with Tina-quant D-dimer (Roche Diagnostics, GmbH, Mannheim, Germany) on Sysmex CA 1500/CS2100i analyzers (Siemens Healthcare AG, Erlangen, Germany).
Statistics
Descriptive data are given as median (25th-75th percentile), as many of the variables were not normally Table 2 Odds ratio (95 % confidence interval) of being in the worst quartile of VAS leg pain, back pain, ODI, or EQ-5D when in the upper half of PAI-1 vs. the lower half of PAI-1 at the different points of outcome 
Results
Preoperative descriptive data of the patient cohort are given in Table 1 . After surgery, there was a substantial improvement in all outcome variables (Fig. 1) . The outcome variables seemed to be stable between the 6 and the 24 months of follow-up.
HsCRP was not significantly associated with any outcome variable at any time, with the exception of VAS back pain 12 months postoperative, when the OR was 2.10 (1.03-4.29) for reporting back pain, when being in the upper half of hsCRP. Fibrinogen and D-dimer was not significantly associated with any outcome variable at any point (data not shown).
PAI-1 was not associated with any of the outcome variables preoperatively, with the exception of a negative association with VAS leg pain ( Table 2 ). High PAI-1 was associated with high VAS back pain, high VAS leg pain, high ODI, and low EQ-5D in the majority of the other follow-up points between 6 and 24 months (Table 2) . Adjustments for sex, BMI, smoking status, and groups of analysis in the logistic regression, increased the point estimates for the OR of PAI-1 with the outcome variables, in most of the associations ( Table 2 ). The number of patients in the different outcome groups at 12 months is shown in Table 3 .
Discussion
In this study, preoperative high PAI-1 predicted poor outcome after surgery of lumbar disc herniation. The only association between hsCRP and outcome was borderline significant, and no significant associations were found for fibrinogen and D-dimer.
We wanted to evaluate whether signs of increased general inflammation could be seen due to the active process of disc herniation [20] . In contradiction to some previous studies on CRP, showing a correlation to sciatica [5, 6] , we found no associations between preoperative hsCRP and postoperative back pain or sciatica. These studies were much smaller than the present study, and may represent chance findings. The study of Briggs et al. [7] was large but was focused on present or recent back pain, not sciatica, in the general population. They found significant associations between obesity, systemic inflammation, and low back pain.
The acute phase reactant and coagulation component fibrinogen, has shown conflicting evidence regarding the association to musculoskeletal pain [7, 14, 21] . Our study does neither support analyzing hsCRP nor fibrinogen as predictors of surgical outcome in a clinical setting.
Impaired fibrinolytic activity has been correlated to inferior outcome in patients operated for lumbar disc herniation [13] . The associations between PAI-1 and outcome showed in our paper, seemed to peak 6-12 months after surgery, and thereafter decrease. PAI-1, hsCRP, and fibrinogen are all acute phase reactants, but as hsCRP or fibrinogen does not show the same association with outcome as PAI-1, it indicates that this association is not mainly due to inflammatory activity. The D-dimer test measures degradation products of fibrin and is used as a marker for thrombus formation [22] . Our study shows very low values with no association to the outcome. The course for PAI-1 might reflect a biological process, like fibrosis, which does not seem to be influenced by preoperative inflammation or thrombus formation.
We can only speculate about the etiology behind these findings. Low fibrinolysis may increase epidural scarring, or elsewhere in the spinal segment. MRI studies do, however, show conflicting results on epidural scarring [23] [24] [25] [26] . The important effect of PAI-1 may not be visible at the Table 3 The number of patients being in the worst quartile (=poor result) of VAS leg pain, VAS back pain, ODI, and of EQ-5D compared to the other 3 quartiles (=good result) at 12 months, based on their preoperative PAI-1 level (lower half compared to upper) The association between PAI-1 and the four outcome variables seems to show a similar pattern. When the different aspects of illness, dysfunction, and quality of life are correlated in the outcome, it strengthens the importance of the findings. Even if the point estimates for the odds ratios are fairly high, the confidence intervals are wide and might lessen the importance of this association at an individual level.
We adjusted the statistical analyses for variables known to substantially affect outcome, or interact with PAI-1, but the association between PAI-1 and outcome remained, or even increased. At least premenopausal women are known to have better effect of fibrinolysis in a cardiovascular context [27] , but women have a slightly worse outcome than men after surgery for lumbar disc herniation [28] . High BMI has been associated with poor outcome after surgical treatment for degenerative disorders in the lumbar spine in one study on spinal stenosis [29] , but not in another [30] . Obesity is associated with high PAI-1 [10] , but also after adjustment for BMI, high PAI-1 was a risk factor for poor outcome in the present study. Smoking is a factor associated with negative impact on most aspects of life. The general perioperative risks are increased [31] and poor outcome has been shown for lumbar disc herniation [32, 33] .
As the laboratory analyses were performed at two different occasions, there is a risk of confounding due to methodological differences; we tried to avoid this eventual influence, by including the two groups of analysis as a possible confounder in itself. The addition of sex, BMI, smoking status, and time of analysis in the logistic regression analysis, rather increased the risk of a poor result, when having high PAI-1.
The cutoff for the outcome variables could be discussed. However, based on previous studies it seemed logical to compare the worst quartile with the others [1, 2] . At 12 months, the poor outcome quartile consisted of patients having a VAS leg pain [30, a VAS back pain [41, an ODI [32, and an EQ-5D \0.62. These cutoffs are much higher than what can be considered acceptable for most individuals. For example, an ODI of 20 or less may be considered ''normal'' [34] . The mean EQ-5D for a Swedish population is 0.86 for persons 40-49 years.
Advantages of our study are the fairly large patient sample and a high follow-up rate, 97 % or higher up to 24 months. The internal validity can thus be considered high.
Our study has some limitations. The lack of non-surgically treated patients and a control group of healthy individuals, could be considered as limitations. We cannot therefore determine the importance of a high PAI-1, or the lack of importance for the other laboratory analyses, in other than surgically treated individuals.
Data for the laboratory analyses were not normally distributed. There are multiple ways of handling such data. One is to dichotomise the variable. As there are no reference values for PAI-1, regarding the current research question, we found it reasonable to choose the median as a breakpoint. Dichotomisation eases presentation but leads to loss of statistical power. In complementary analyses, we logarithmised the laboratory variables to achieve a more normal distribution, and then used these in the logistic regression. The results achieved were similar with an increase in OR for a poor outcome with each unit increase of PAI-1 (data not shown).
In summary, this study cannot confirm that hsCRP is associated with pain or disability after surgery of lumbar disc herniation, but having PAI-1 in the upper half more than doubled the risk of having a poor outcome 1 year after surgery for lumbar disc herniation. This association may not be sufficient to use as a predictor on an individual level, but does suggest that fibrinolysis is of importance for the outcome.
